Patent ID: 9139542
Filing Date: 2015-09-22
Classification: C07D

Abstract:
1. A crystalline form of (2Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-(3-N-tert-butoxycarbonylaminopropoxyimino)acetic acid triethylamine salt; wherein the crystalline form is characterized by at least one of the following properties: (a) a powder x-ray diffraction pattern comprising diffraction peaks at 2θ values of 5.00±0.20, 12.92±0.20, 15.00±0.20, 16.92±0.20, 22.36±0.20, 23.36±0.20 and 24.54±0.20; (b) a melting onset temperature of about 139° C.; or (c) crystalline parameters at 293 K comprising (i) a monoclinic crystal system, (ii) a P2